Sun Pharma Advanced Research Co (NSE:SPARC) Total Stockholders Equity : ₹-2,169.5 Mil (As of Mar. 2025)

View and export this data going back to 2007. Start your Free Trial

What is Sun Pharma Advanced Research Co Total Stockholders Equity?

Sun Pharma Advanced Research Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ₹-2,169.5 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Sun Pharma Advanced Research Co's Book Value per Share for the quarter that ended in Mar. 2025 was ₹-6.69. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Sun Pharma Advanced Research Co's Debt-to-Equity for the quarter that ended in Mar. 2025 was -1.22.

Sun Pharma Advanced Research Co Total Stockholders Equity Historical Data

The historical data trend for Sun Pharma Advanced Research Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharma Advanced Research Co Total Stockholders Equity Chart

Sun Pharma Advanced Research Co Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Total Stockholders Equity

Get a 7-Day Free Trial

-1,682.52

312.26

5,127.75

1,257.55

-2,169.48

Sun Pharma Advanced Research Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															1,257.55	-	-	-	-2,169.48

Sun Pharma Advanced Research Co (NSE:SPARC) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Sun Pharma Advanced Research Co's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-2169.48	-	0)	/	324.522
	=	-6.69

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Sun Pharma Advanced Research Co's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1581.853	+	1069.494)	/	-2169.48
	=	-1.22

Sun Pharma Advanced Research Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Sun Pharma Advanced Research Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Sun Pharma Advanced Research Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharma Advanced Research Co Ltd (NSE:SPARC) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

532872:India

Address

Off Mahakali Caves Road, 17-B, Mahal Industrial Estate, Andheri (East), Mumbai, MH, IND, 400093

Website

https://www.sparc.life

Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in othe4r countries.

Sun Pharma Advanced Research Co Headlines

No Headlines